Global Implantable Drug-Eluting Devices Sales Market Report 2021

1 Implantable Drug-Eluting Devices Market Overview
1.1 Implantable Drug-Eluting Devices Product Scope
1.2 Implantable Drug-Eluting Devices Segment by Type
1.2.1 Global Implantable Drug-Eluting Devices Sales by Type (2016 & 2021 & 2027)
1.2.2 Implantable Drug Infusion Pumps
1.2.3 Intraocular Drug-Eluting Devices
1.2.4 Contraceptive Drug-Eluting Devices
1.2.5 Drug-Eluting Stents
1.2.6 Others
1.3 Implantable Drug-Eluting Devices Segment by Application
1.3.1 Global Implantable Drug-Eluting Devices Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Diabetes
1.3.3 Contraception
1.3.4 HIV/AIDS Prevention
1.3.5 Chronic Pain Management
1.3.6 Cardiovascular
1.3.7 Ophthalmology
1.3.8 Oncology
1.3.9 Others
1.4 Implantable Drug-Eluting Devices Market Estimates and Forecasts (2016-2027)
1.4.1 Global Implantable Drug-Eluting Devices Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Implantable Drug-Eluting Devices Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Implantable Drug-Eluting Devices Price Trends (2016-2027)

2 Implantable Drug-Eluting Devices Estimates and Forecasts by Region
2.1 Global Implantable Drug-Eluting Devices Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Implantable Drug-Eluting Devices Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Implantable Drug-Eluting Devices Sales Market Share by Region (2016-2021)
2.2.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2016-2021)
2.3 Global Implantable Drug-Eluting Devices Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Implantable Drug-Eluting Devices Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Implantable Drug-Eluting Devices Estimates and Projections (2016-2027)
2.4.2 Europe Implantable Drug-Eluting Devices Estimates and Projections (2016-2027)
2.4.3 China Implantable Drug-Eluting Devices Estimates and Projections (2016-2027)
2.4.4 Japan Implantable Drug-Eluting Devices Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Implantable Drug-Eluting Devices Estimates and Projections (2016-2027)
2.4.6 India Implantable Drug-Eluting Devices Estimates and Projections (2016-2027)
3 Global Implantable Drug-Eluting Devices Competition Landscape by Players
3.1 Global Top Implantable Drug-Eluting Devices Players by Sales (2016-2021)
3.2 Global Top Implantable Drug-Eluting Devices Players by Revenue (2016-2021)
3.3 Global Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Implantable Drug-Eluting Devices as of 2020)
3.4 Global Implantable Drug-Eluting Devices Average Price by Company (2016-2021)
3.5 Manufacturers Implantable Drug-Eluting Devices Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Implantable Drug-Eluting Devices Market Size by Type
4.1 Global Implantable Drug-Eluting Devices Historic Market Review by Type (2016-2021)
4.1.1 Global Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2021)
4.1.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2016-2021)
4.1.3 Global Implantable Drug-Eluting Devices Price by Type (2016-2021)
4.2 Global Implantable Drug-Eluting Devices Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Implantable Drug-Eluting Devices Sales Forecast by Type (2022-2027)
4.2.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Type (2022-2027)
4.2.3 Global Implantable Drug-Eluting Devices Price Forecast by Type (2022-2027)
5 Global Implantable Drug-Eluting Devices Market Size by Application
5.1 Global Implantable Drug-Eluting Devices Historic Market Review by Application (2016-2021)
5.1.1 Global Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2021)
5.1.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2016-2021)
5.1.3 Global Implantable Drug-Eluting Devices Price by Application (2016-2021)
5.2 Global Implantable Drug-Eluting Devices Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Implantable Drug-Eluting Devices Sales Forecast by Application (2022-2027)
5.2.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Application (2022-2027)
5.2.3 Global Implantable Drug-Eluting Devices Price Forecast by Application (2022-2027)

6 North America Implantable Drug-Eluting Devices Market Facts & Figures
6.1 North America Implantable Drug-Eluting Devices Sales by Company
6.1.1 North America Implantable Drug-Eluting Devices Sales by Company (2016-2021)
6.1.2 North America Implantable Drug-Eluting Devices Revenue by Company (2016-2021)
6.2 North America Implantable Drug-Eluting Devices Sales Breakdown by Type
6.2.1 North America Implantable Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
6.2.2 North America Implantable Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
6.3 North America Implantable Drug-Eluting Devices Sales Breakdown by Application
6.3.1 North America Implantable Drug-Eluting Devices Sales Breakdown by Application (2016-2021)
6.3.2 North America Implantable Drug-Eluting Devices Sales Breakdown by Application (2022-2027)

7 Europe Implantable Drug-Eluting Devices Market Facts & Figures
7.1 Europe Implantable Drug-Eluting Devices Sales by Company
7.1.1 Europe Implantable Drug-Eluting Devices Sales by Company (2016-2021)
7.1.2 Europe Implantable Drug-Eluting Devices Revenue by Company (2016-2021)
7.2 Europe Implantable Drug-Eluting Devices Sales Breakdown by Type
7.2.1 Europe Implantable Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
7.2.2 Europe Implantable Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
7.3 Europe Implantable Drug-Eluting Devices Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China Implantable Drug-Eluting Devices Market Facts & Figures
8.1 China Implantable Drug-Eluting Devices Sales by Company
8.1.1 China Implantable Drug-Eluting Devices Sales by Company (2016-2021)
8.1.2 China Implantable Drug-Eluting Devices Revenue by Company (2016-2021)
8.2 China Implantable Drug-Eluting Devices Sales Breakdown by Type
8.2.1 China Implantable Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
8.2.2 China Implantable Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
8.3 China Implantable Drug-Eluting Devices Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)

9 Japan Implantable Drug-Eluting Devices Market Facts & Figures
9.1 Japan Implantable Drug-Eluting Devices Sales by Company
9.1.1 Japan Implantable Drug-Eluting Devices Sales by Company (2016-2021)
9.1.2 Japan Implantable Drug-Eluting Devices Revenue by Company (2016-2021)
9.2 Japan Implantable Drug-Eluting Devices Sales Breakdown by Type
9.2.1 Japan Implantable Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
9.2.2 Japan Implantable Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
9.3 Japan Implantable Drug-Eluting Devices Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Implantable Drug-Eluting Devices Market Facts & Figures
10.1 Southeast Asia Implantable Drug-Eluting Devices Sales by Company
10.1.1 Southeast Asia Implantable Drug-Eluting Devices Sales by Company (2016-2021)
10.1.2 Southeast Asia Implantable Drug-Eluting Devices Revenue by Company (2016-2021)
10.2 Southeast Asia Implantable Drug-Eluting Devices Sales Breakdown by Type
10.2.1 Southeast Asia Implantable Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Implantable Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Implantable Drug-Eluting Devices Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Implantable Drug-Eluting Devices Market Facts & Figures
11.1 India Implantable Drug-Eluting Devices Sales by Company
11.1.1 India Implantable Drug-Eluting Devices Sales by Company (2016-2021)
11.1.2 India Implantable Drug-Eluting Devices Revenue by Company (2016-2021)
11.2 India Implantable Drug-Eluting Devices Sales Breakdown by Type
11.2.1 India Implantable Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
11.2.2 India Implantable Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
11.3 India Implantable Drug-Eluting Devices Sales Breakdown by Application
11.3.1 India Implantable Drug-Eluting Devices Sales Breakdown by Application (2016-2021)
11.3.2 India Implantable Drug-Eluting Devices Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Implantable Drug-Eluting Devices Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Implantable Drug-Eluting Devices Products Offered
12.1.5 Pfizer Recent Development
12.2 Medtronic
12.2.1 Medtronic Corporation Information
12.2.2 Medtronic Business Overview
12.2.3 Medtronic Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Medtronic Implantable Drug-Eluting Devices Products Offered
12.2.5 Medtronic Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Implantable Drug-Eluting Devices Products Offered
12.3.5 Merck Recent Development
12.4 Bayer AG
12.4.1 Bayer AG Corporation Information
12.4.2 Bayer AG Business Overview
12.4.3 Bayer AG Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bayer AG Implantable Drug-Eluting Devices Products Offered
12.4.5 Bayer AG Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Business Overview
12.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Abbott
12.6.1 Abbott Corporation Information
12.6.2 Abbott Business Overview
12.6.3 Abbott Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Abbott Implantable Drug-Eluting Devices Products Offered
12.6.5 Abbott Recent Development
12.7 Surmodics
12.7.1 Surmodics Corporation Information
12.7.2 Surmodics Business Overview
12.7.3 Surmodics Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Surmodics Implantable Drug-Eluting Devices Products Offered
12.7.5 Surmodics Recent Development
12.8 Boston Scientific Corporation
12.8.1 Boston Scientific Corporation Corporation Information
12.8.2 Boston Scientific Corporation Business Overview
12.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Products Offered
12.8.5 Boston Scientific Corporation Recent Development
12.9 Titan Pharmaceuticals, Inc.
12.9.1 Titan Pharmaceuticals, Inc. Corporation Information
12.9.2 Titan Pharmaceuticals, Inc. Business Overview
12.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Products Offered
12.9.5 Titan Pharmaceuticals, Inc. Recent Development
12.10 BIOTRONIK
12.10.1 BIOTRONIK Corporation Information
12.10.2 BIOTRONIK Business Overview
12.10.3 BIOTRONIK Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.10.4 BIOTRONIK Implantable Drug-Eluting Devices Products Offered
12.10.5 BIOTRONIK Recent Development
12.11 Allergan
12.11.1 Allergan Corporation Information
12.11.2 Allergan Business Overview
12.11.3 Allergan Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Allergan Implantable Drug-Eluting Devices Products Offered
12.11.5 Allergan Recent Development
12.12 Bausch & Lomb
12.12.1 Bausch & Lomb Corporation Information
12.12.2 Bausch & Lomb Business Overview
12.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Products Offered
12.12.5 Bausch & Lomb Recent Development
12.13 REVA Medical
12.13.1 REVA Medical Corporation Information
12.13.2 REVA Medical Business Overview
12.13.3 REVA Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.13.4 REVA Medical Implantable Drug-Eluting Devices Products Offered
12.13.5 REVA Medical Recent Development
12.14 MicroPort Medical
12.14.1 MicroPort Medical Corporation Information
12.14.2 MicroPort Medical Business Overview
12.14.3 MicroPort Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.14.4 MicroPort Medical Implantable Drug-Eluting Devices Products Offered
12.14.5 MicroPort Medical Recent Development

13 Implantable Drug-Eluting Devices Manufacturing Cost Analysis
13.1 Implantable Drug-Eluting Devices Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Implantable Drug-Eluting Devices
13.4 Implantable Drug-Eluting Devices Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Implantable Drug-Eluting Devices Distributors List
14.3 Implantable Drug-Eluting Devices Customers

15 Market Dynamics
15.1 Implantable Drug-Eluting Devices Market Trends
15.2 Implantable Drug-Eluting Devices Drivers
15.3 Implantable Drug-Eluting Devices Market Challenges
15.4 Implantable Drug-Eluting Devices Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Implantable Drug-Eluting Devices Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Implantable Drug-Eluting Devices Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Implantable Drug-Eluting Devices Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Implantable Drug-Eluting Devices Sales (K Units) by Region (2016-2021)
Table 5. Global Implantable Drug-Eluting Devices Sales Market Share by Region (2016-2021)
Table 6. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Implantable Drug-Eluting Devices Revenue Share by Region (2016-2021)
Table 8. Global Implantable Drug-Eluting Devices Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Implantable Drug-Eluting Devices Revenue Share Forecast by Region (2022-2027)
Table 12. Global Implantable Drug-Eluting Devices Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Implantable Drug-Eluting Devices Sales Share by Company (2016-2021)
Table 14. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Implantable Drug-Eluting Devices Revenue Share by Company (2016-2021)
Table 16. Global Implantable Drug-Eluting Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Implantable Drug-Eluting Devices as of 2020)
Table 17. Global Implantable Drug-Eluting Devices Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Implantable Drug-Eluting Devices Manufacturing Sites and Area Served
Table 19. Manufacturers Implantable Drug-Eluting Devices Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Implantable Drug-Eluting Devices Sales (K Units) by Type (2016-2021)
Table 22. Global Implantable Drug-Eluting Devices Sales Share by Type (2016-2021)
Table 23. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Type (2016-2021)
Table 25. Global Implantable Drug-Eluting Devices Sales Share by Type (2022-2027)
Table 26. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Implantable Drug-Eluting Devices Revenue Share by Type (2022-2027)
Table 28. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Type (2022-2027)
Table 29. Global Implantable Drug-Eluting Devices Sales (K Units) by Application (2016-2021)
Table 30. Global Implantable Drug-Eluting Devices Sales Share by Application (2016-2021)
Table 31. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Application (2016-2021)
Table 33. Global Implantable Drug-Eluting Devices Sales (K Units) by Application (2022-2027)
Table 34. Global Implantable Drug-Eluting Devices Sales Share by Application (2022-2027)
Table 35. Global Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Implantable Drug-Eluting Devices Revenue Share by Application (2022-2027)
Table 37. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Application (2022-2027)
Table 38. North America Implantable Drug-Eluting Devices Sales (K Units) by Company (2016-2021)
Table 39. North America Implantable Drug-Eluting Devices Sales Market Share by Company (2016-2021)
Table 40. North America Implantable Drug-Eluting Devices Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Implantable Drug-Eluting Devices Revenue Market Share by Company (2016-2021)
Table 42. North America Implantable Drug-Eluting Devices Sales by Type (2016-2021) & (K Units)
Table 43. North America Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 44. North America Implantable Drug-Eluting Devices Sales by Type (2022-2027) & (K Units)
Table 45. North America Implantable Drug-Eluting Devices Sales Market Share by Type (2022-2027)
Table 46. North America Implantable Drug-Eluting Devices Sales by Application (2016-2021) & (K Units)
Table 47. North America Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 48. North America Implantable Drug-Eluting Devices Sales by Application (2022-2027) & (K Units)
Table 49. North America Implantable Drug-Eluting Devices Sales Market Share by Application (2022-2027)
Table 50. Europe Implantable Drug-Eluting Devices Sales (K Units) by Company (2016-2021)
Table 51. Europe Implantable Drug-Eluting Devices Sales Market Share by Company (2016-2021)
Table 52. Europe Implantable Drug-Eluting Devices Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Implantable Drug-Eluting Devices Revenue Market Share by Company (2016-2021)
Table 54. Europe Implantable Drug-Eluting Devices Sales by Type (2016-2021) & (K Units)
Table 55. Europe Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 56. Europe Implantable Drug-Eluting Devices Sales by Type (2022-2027) & (K Units)
Table 57. Europe Implantable Drug-Eluting Devices Sales Market Share by Type (2022-2027)
Table 58. Europe Implantable Drug-Eluting Devices Sales by Application (2016-2021) & (K Units)
Table 59. Europe Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 60. Europe Implantable Drug-Eluting Devices Sales by Application (2022-2027) & (K Units)
Table 61. Europe Implantable Drug-Eluting Devices Sales Market Share by Application (2022-2027)
Table 62. China Implantable Drug-Eluting Devices Sales (K Units) by Company (2016-2021)
Table 63. China Implantable Drug-Eluting Devices Sales Market Share by Company (2016-2021)
Table 64. China Implantable Drug-Eluting Devices Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Implantable Drug-Eluting Devices Revenue Market Share by Company (2016-2021)
Table 66. China Implantable Drug-Eluting Devices Sales by Type (2016-2021) & (K Units)
Table 67. China Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 68. China Implantable Drug-Eluting Devices Sales by Type (2022-2027) & (K Units)
Table 69. China Implantable Drug-Eluting Devices Sales Market Share by Type (2022-2027)
Table 70. China Implantable Drug-Eluting Devices Sales by Application (2016-2021) & (K Units)
Table 71. China Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 72. China Implantable Drug-Eluting Devices Sales by Application (2022-2027) & (K Units)
Table 73. China Implantable Drug-Eluting Devices Sales Market Share by Application (2022-2027)
Table 74. Japan Implantable Drug-Eluting Devices Sales (K Units) by Company (2016-2021)
Table 75. Japan Implantable Drug-Eluting Devices Sales Market Share by Company (2016-2021)
Table 76. Japan Implantable Drug-Eluting Devices Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Implantable Drug-Eluting Devices Revenue Market Share by Company (2016-2021)
Table 78. Japan Implantable Drug-Eluting Devices Sales by Type (2016-2021) & (K Units)
Table 79. Japan Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 80. Japan Implantable Drug-Eluting Devices Sales by Type (2022-2027) & (K Units)
Table 81. Japan Implantable Drug-Eluting Devices Sales Market Share by Type (2022-2027)
Table 82. Japan Implantable Drug-Eluting Devices Sales by Application (2016-2021) & (K Units)
Table 83. Japan Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 84. Japan Implantable Drug-Eluting Devices Sales by Application (2022-2027) & (K Units)
Table 85. Japan Implantable Drug-Eluting Devices Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Implantable Drug-Eluting Devices Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Implantable Drug-Eluting Devices Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Implantable Drug-Eluting Devices Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Implantable Drug-Eluting Devices Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Implantable Drug-Eluting Devices Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Implantable Drug-Eluting Devices Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Implantable Drug-Eluting Devices Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Application (2022-2027)
Table 98. India Implantable Drug-Eluting Devices Sales (K Units) by Company (2016-2021)
Table 99. India Implantable Drug-Eluting Devices Sales Market Share by Company (2016-2021)
Table 100. India Implantable Drug-Eluting Devices Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Implantable Drug-Eluting Devices Revenue Market Share by Company (2016-2021)
Table 102. India Implantable Drug-Eluting Devices Sales by Type (2016-2021) & (K Units)
Table 103. India Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 104. India Implantable Drug-Eluting Devices Sales by Type (2022-2027) & (K Units)
Table 105. India Implantable Drug-Eluting Devices Sales Market Share by Type (2022-2027)
Table 106. India Implantable Drug-Eluting Devices Sales by Application (2016-2021) & (K Units)
Table 107. India Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 108. India Implantable Drug-Eluting Devices Sales by Application (2022-2027) & (K Units)
Table 109. India Implantable Drug-Eluting Devices Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Pfizer Implantable Drug-Eluting Devices Product
Table 114. Pfizer Recent Development
Table 115. Medtronic Corporation Information
Table 116. Medtronic Description and Business Overview
Table 117. Medtronic Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Medtronic Implantable Drug-Eluting Devices Product
Table 119. Medtronic Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Merck Implantable Drug-Eluting Devices Product
Table 124. Merck Recent Development
Table 125. Bayer AG Corporation Information
Table 126. Bayer AG Description and Business Overview
Table 127. Bayer AG Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Bayer AG Implantable Drug-Eluting Devices Product
Table 129. Bayer AG Recent Development
Table 130. Johnson & Johnson Corporation Information
Table 131. Johnson & Johnson Description and Business Overview
Table 132. Johnson & Johnson Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Johnson & Johnson Implantable Drug-Eluting Devices Product
Table 134. Johnson & Johnson Recent Development
Table 135. Abbott Corporation Information
Table 136. Abbott Description and Business Overview
Table 137. Abbott Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Abbott Implantable Drug-Eluting Devices Product
Table 139. Abbott Recent Development
Table 140. Surmodics Corporation Information
Table 141. Surmodics Description and Business Overview
Table 142. Surmodics Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Surmodics Implantable Drug-Eluting Devices Product
Table 144. Surmodics Recent Development
Table 145. Boston Scientific Corporation Corporation Information
Table 146. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Boston Scientific Corporation Description and Business Overview
Table 148. Boston Scientific Corporation Implantable Drug-Eluting Devices Product
Table 149. Boston Scientific Corporation Recent Development
Table 150. Titan Pharmaceuticals, Inc. Corporation Information
Table 151. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Titan Pharmaceuticals, Inc. Description and Business Overview
Table 153. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product
Table 154. Titan Pharmaceuticals, Inc. Recent Development
Table 155. BIOTRONIK Corporation Information
Table 156. BIOTRONIK Description and Business Overview
Table 157. BIOTRONIK Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. BIOTRONIK Implantable Drug-Eluting Devices Product
Table 159. BIOTRONIK Recent Development
Table 160. Allergan Corporation Information
Table 161. Allergan Description and Business Overview
Table 162. Allergan Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Allergan Implantable Drug-Eluting Devices Product
Table 164. Allergan Recent Development
Table 165. Bausch & Lomb Corporation Information
Table 166. Bausch & Lomb Description and Business Overview
Table 167. Bausch & Lomb Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Bausch & Lomb Implantable Drug-Eluting Devices Product
Table 169. Bausch & Lomb Recent Development
Table 170. REVA Medical Corporation Information
Table 171. REVA Medical Description and Business Overview
Table 172. REVA Medical Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. REVA Medical Implantable Drug-Eluting Devices Product
Table 174. REVA Medical Recent Development
Table 175. MicroPort Medical Corporation Information
Table 176. MicroPort Medical Description and Business Overview
Table 177. MicroPort Medical Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. MicroPort Medical Implantable Drug-Eluting Devices Product
Table 179. MicroPort Medical Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Implantable Drug-Eluting Devices Distributors List
Table 183. Implantable Drug-Eluting Devices Customers List
Table 184. Implantable Drug-Eluting Devices Market Trends
Table 185. Implantable Drug-Eluting Devices Market Drivers
Table 186. Implantable Drug-Eluting Devices Market Challenges
Table 187. Implantable Drug-Eluting Devices Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Implantable Drug-Eluting Devices Product Picture
Figure 2. Global Implantable Drug-Eluting Devices Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Implantable Drug-Eluting Devices Sales Market Share by Application in 2021 & 2027
Figure 6. Diabetes Examples
Figure 7. Contraception Examples
Figure 8. HIV/AIDS Prevention Examples
Figure 9. Chronic Pain Management Examples
Figure 10. Cardiovascular Examples
Figure 11. Ophthalmology Examples
Figure 12. Oncology Examples
Figure 13. Others Examples
Figure 14. Global Implantable Drug-Eluting Devices Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Implantable Drug-Eluting Devices Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Implantable Drug-Eluting Devices Sales (K Units) Growth Rate (2016-2027)
Figure 17. Global Implantable Drug-Eluting Devices Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 18. Global Implantable Drug-Eluting Devices Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Implantable Drug-Eluting Devices Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Implantable Drug-Eluting Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America Implantable Drug-Eluting Devices Sales (K Units) Growth Rate (2016-2027)
Figure 22. Europe Implantable Drug-Eluting Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe Implantable Drug-Eluting Devices Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China Implantable Drug-Eluting Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China Implantable Drug-Eluting Devices Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan Implantable Drug-Eluting Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan Implantable Drug-Eluting Devices Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Implantable Drug-Eluting Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Implantable Drug-Eluting Devices Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India Implantable Drug-Eluting Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India Implantable Drug-Eluting Devices Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Global 5 Largest Implantable Drug-Eluting Devices Players Market Share by Revenue in Implantable Drug-Eluting Devices: 2016 & 2020
Figure 33. Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 34. Global Implantable Drug-Eluting Devices Revenue Share by Type (2016-2021)
Figure 35. Global Implantable Drug-Eluting Devices Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Global Implantable Drug-Eluting Devices Revenue Share by Application (2016-2021)
Figure 37. Global Implantable Drug-Eluting Devices Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Implantable Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 39. North America Implantable Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 40. Europe Implantable Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 41. Europe Implantable Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 42. China Implantable Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 43. China Implantable Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 44. Japan Implantable Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 45. Japan Implantable Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 46. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 47. Southeast Asia Implantable Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 48. India Implantable Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 49. India Implantable Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Implantable Drug-Eluting Devices
Figure 52. Manufacturing Process Analysis of Implantable Drug-Eluting Devices
Figure 53. Implantable Drug-Eluting Devices Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.